Dr. Berchmans John, MD

Dr. John practices at Jnp Surgical Associates PA in Arlington, Texas.

Dr. John's NPI, 1073556403, was assigned on June 14, 2006. Dr. John graduated from Kottayam Medical College in 1973. Dr. John's Texas license number on file is F5589.

Dr. John's primary practice is Jnp Surgical Associates PA, at 515 W Mayfield Rd, Arlington, TX 76014 in Tarrant County. The practice phone is (817) 419-9200.

Dr. John's primary practice is Jnp Surgical Associates PA in Arlington, Texas. The medical group on file is Texas Oncology. Dmand AI also links Dr. John to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. John practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. John's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. John is board certified in therapeutic radiology by the American Board of Radiology. Dmand AI has Dr. John's licenses on file in 2 states: Texas and Florida.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. John treats.

CMS data shows 6,105 Medicare services from Dr. John across 23 procedure codes in 2024, for 199 Medicare patients. Medicare paid $356,523 for them. Every service was in an office.

CMS counts 199 Medicare patients who saw Dr. John in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. John's median patient age at 70, with 61% women.

In 2024, Dr. John wrote 188 Medicare Part D claims for 65 patients. 77% of them were for generic drugs. CMS names the drug for 96 of them, across 6 drugs with 11 or more claims each, at $2,642 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. John for performance year 2024, reported through an alternative payment model (APM). Dr. John accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. John to 1 clinical trial. Conditions studied include Lung Neoplasms and Thoracic Neoplasms.

CMS Open Payments shows 2 general payments to Dr. John from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $50.

Dr. John graduated from Kottayam Medical College in 1973.

Dr. John is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.